Evaluate Pathogens and Immunity to Acute Otitis Media in Healthy Children.

Overview

The purpose of this study is to Evaluate Pathogens and Immunity to Acute Otitis Media in Healthy Children.

Full Title of Study: “A Study Evaluating Pathogens and Immunity to Acute Otitis Media and Nasopharyngeal Colonization in Healthy Children.”

Study Type

  • Study Type: Observational
  • Study Design
    • Time Perspective: Prospective
  • Study Primary Completion Date: December 2025

Detailed Description

A prospective evaluation of bacterial pathogens Streptococcus. pneumoniae, Haemophilus influenzae, Moraxella. catarrhalis and Staphylococcus aureus and their antibiotic susceptibility when colonizing the nasopharynx and/or causing acute otitis media in the years 2015-2025. The goal will be to recruit children into a prospective group beginning at 6 months of age and followed to 36 months of age in suburban Rochester, New York. Nasopharyngeal and nasal wash samples will be obtained at each well child visit and at acute otitis media (AOM) episodes. Middle ear fluid will be obtained from every child with an acute otitis media episode who undergoes a tympanocentesis procedure. All of the nasopharyngeal and middle ear fluid samples collected will be tested by standard microbiologic techniques to identify the presence of 4 potential otopathogens (S. pneumoniae, H. influenzae, M. catarrhalis and S. aureus). All S. pneumoniae will undergo serotyping and antibiotic susceptibility testing. All samples that are culture negative will be evaluated with a multi-locus PCR test to examine for presence of potential otopathogens.

Interventions

  • Other: procedures
    • Nasopharyngeal swab, nasopharyngeal wash, tympanocentesis (if acute otitis media occurs), venipuncture

Arms, Groups and Cohorts

  • Healthy children
    • 6-36 months of age who will have the following study procedures: Venipuncture, Nasopharyngeal swab, nasopharyngeal wash, tympanocentesis

Clinical Trial Outcome Measures

Primary Measures

  • The distribution of bacteria causing acute otitis media.
    • Time Frame: 10 years
    • In this study, we are exploring the three main bacteria (Streptococcus pneumoniae, Haemophilus influenzae, Moraxella catarrhalis) isolated from middle ear fluid samples (obtained by tympanocentesis) during acute otitis media episode in children ages 6-36 months.

Secondary Measures

  • The distribution of potential otopathogens colonizing the nasopharynx.
    • Time Frame: 10 years
    • In this study we are exploring the three main bacteria (Streptococcus pneumoniae, Haemophilus influenzae, Moraxella catarrhalis) isolated from nasopharynx of children during their routine healthy visits at 6-36 months of age during an AOM episode.

Participating in This Clinical Trial

Inclusion Criteria

Healthy Children:

  • Male or female age greater than/equal to 6 months or less than/equal to 36 months old. – Parent/guardian willing to bring to all study visits Exclusion Criteria:

  • Any major illness/condition that in investigator opinion would put subject at risk during study. – Otorrhea or tympanostomy tubes present in either ear @ time of enrollment. – Direct descendant of study site personnel. – Subjects < 6 months old or >36 months old at the time of enrollment

Gender Eligibility: All

Minimum Age: 6 Months

Maximum Age: 36 Months

Are Healthy Volunteers Accepted: Accepts Healthy Volunteers

Investigator Details

  • Lead Sponsor
    • Rochester General Hospital
  • Provider of Information About this Clinical Study
    • Principal Investigator: Michael Pichichero, MD, Director, Rochester General Hospital Research Institute – Rochester General Hospital
  • Overall Official(s)
    • Michael E Pichichero, MD, Principal Investigator, Rochester General Hospital

Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.

At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.